Oral care products maker Prisyna said it has raised $6 million in growth equity investment to develop and gain regulatory approval for its products.
Claremont-based Prisyna, a unit of Synedgen Inc., said the financing was led by Andrew Miller through a private investment.
The company plans to use the funding for the advanced development, regulatory approval and marketing efforts for the expansion of its pipeline and in support of current products.
Prisyna’s products include Moistagen , a potential…
Oral care products maker Prisyna said it has raised $6 million in growth equity investment to develop and gain regulatory approval for its products.
Claremont-based Prisyna, a unit of Synedgen Inc., said the financing was led by Andrew Miller through a private investment.
The company plans to use the funding for the advanced development, regulatory approval and marketing efforts for the expansion of its pipeline and in support of current products.
Prisyna’s products include Moistagen , a potential…